| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |